Lv6
1830 积分 2021-10-22 加入
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
4小时前
已完结
P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape
5小时前
求助中
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
1个月前
已完结
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases
1个月前
已完结
Targeting common EGFR mutations in non-small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors
1个月前
已完结
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases
1个月前
已完结
Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial
2个月前
已完结
Consensus on the diagnosis and treatment of unresectable stage III driver gene-positive non-small cell lung cancer
2个月前
已完结
Navigating controversies in stage III NSCLC: a multidisciplinary case discussion on evolving treatment paradigms
2个月前
已完结
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
2个月前
已完结
皖公网安备34019202002308
